With reference to the above subject, pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board of Directors of the company, at its meeting held today i.e. 25th May, 2019, has taken on record and approved the Audited Standalone and Consolidated Financial Results of the Company under Ind AS for the quarter and for the year ended 31st March, 2019 and approved the following matters.

Pdf Link: Suven Life Sciences Ltd. - Audited Standalone And Consolidated Financial Results Under Ind AS For The Quarter And For The Financial Year Ended 31St March, 2019

Source : BSE - www.bseindia.com

comment COMMENT NOW